Korean Journal of Veterinary Service (한국동물위생학회지)

The Korean Society of Veterinary Service (한국동물위생학회)
권호 표지
DOI QR코드

DOI QR Code

Evaluation of efficacy of a commercial vaccine stress-relieving agent to reduce the adverse effects of foot-and-mouth disease vaccination site in pig

시판 백신접종 스트레스 완화제의 돼지 구제역 백신 접종부위 부작용 발생 저감 효과 평가

  • Park, Yu-Ri (College of Veterinary Medicine & Animal Disease Intervention Center, Kyungpook National University) ;
  • Lim, Da-Rae (College of Veterinary Medicine & Animal Disease Intervention Center, Kyungpook National University) ;
  • Kim, Hye-Ryung (College of Veterinary Medicine & Animal Disease Intervention Center, Kyungpook National University) ;
  • Park, Min-Ji (College of Veterinary Medicine & Animal Disease Intervention Center, Kyungpook National University) ;
  • Kim, Bumseok (College of Veterinary Medicine, Chonbuk National University) ;
  • Kim, Won-Il (College of Veterinary Medicine, Chonbuk National University) ;
  • Hong, Chang-Ho (SAMYANG ANIPHARM Co., LTD.) ;
  • Kim, Sung-Nyon (SAMYANG ANIPHARM Co., LTD.) ;
  • Park, Choi-Kyu (College of Veterinary Medicine & Animal Disease Intervention Center, Kyungpook National University)
  • 박유리 (경북대학교 수의과대학 & 수의전염병제어센터) ;
  • 임다래 (경북대학교 수의과대학 & 수의전염병제어센터) ;
  • 김혜령 (경북대학교 수의과대학 & 수의전염병제어센터) ;
  • 박민지 (경북대학교 수의과대학 & 수의전염병제어센터) ;
  • 김범석 (전북대학교 수의과대학) ;
  • 김원일 (전북대학교 수의과대학) ;
  • 홍창호 ((주)삼양애니팜) ;
  • 김성년 ((주)삼양애니팜) ;
  • 박최규 (경북대학교 수의과대학 & 수의전염병제어센터)
  • Received : 2017.07.22
  • Accepted : 2017.09.11
  • Published : 2017.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

In this study, we evaluated the efficacy of a commercial vaccine stress-relieving agent (Anti VS-2 injection) to reduce the adverse effects of foot-and-mouth disease (FMD) vaccination site in 120 pigs on two tested pig farms. The results showed that incidence of pig with abnormal meat, size of abnormal meat and weight of discarded abnormal meat are significantly decreased in Anti VS-2 injection-supplemented FMD vaccinated pig groups (n=60) compared to the non-supplemented FMD vaccinated pig groups (n=60) (P<0.05). And the average economic loss by discard of abnormal meat were estimated 99,382 won or 21,514 won in the non-supplemented FMD vaccinated groups or in the Anti VS-2 injection-supplemented FMD vaccinated groups, respectively, showing that the cost saving effect was 78% (77,869 won). In conclusion, it is expected to reduce the incidence and severity of abnormal meat in the FMD vaccinated pigs and to contribute not only to the reduced economic loss of pig farmers but also to the promotion of food hygiene when the Anti VS-2 injection is mixed with FMD vaccine.

Keywords

References

  1. 농림축산검역본부. 2016. 도축하는 가축 및 그 식육에 대한 세부검사기준, 농림축산검역본부고시 제2016-18호.
  2. 박최규. 2012. 구제역 백신의 특성과 올바른 사용방법. 대한수의사회지 48: 144-149.
  3. 한국동물약품협회. 2017. 동물약품 편람 (http://www.kahpa.or.kr).
  4. Aucouturier J, Dupuis L, Ganne V. 2001. Adjuvants designed for veterinary and human vaccines. Vaccine 19: 2666-2672. https://doi.org/10.1016/S0264-410X(00)00498-9
  5. Bahenmann HG, Mesquita JA. 1987. Oil adjuvant vaccine against foot-and-mouth disease. Biol Centr Panam Fiebre 53: 25-30.
  6. Barnett PV, Pullen L, Williams L, Doel T. 1996. International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants. Vaccine 14: 1187-1196. https://doi.org/10.1016/S0264-410X(96)00055-2
  7. Choi SH, Pak SI. 2015. Economic burden of foot-and-mouth disease vaccination-induced injection site lesions in slaughtered pigs and its causal relationship. J Prev Vet Med 39: 153-156. https://doi.org/10.13041/jpvm.2015.39.4.153
  8. Hyun BH, Kim JJ, Lim SI, Hong CH, Min PH, Song JY. 2011. Development and evaluation of a vaccine stress reliever for pigs. 5th Vaccine and ISV annual Global Congress Proceeding P3.4.9.
  9. Jamel SM, Belsham GJ. 2013. Food-and-mouth disease: past, present and future. Vet Res 44: 116. https://doi.org/10.1186/1297-9716-44-116
  10. Jeong HK. 2012. Research report on causal analysis of injection site tissue reaction due to foot-and-mouth disease vaccination and mitigation strategy. pp.62-67, Dodramnonghyup.
  11. Kim T, Ryoo S, Nah JJ, Sagong MG, Lee S, Lee KN, Ko YJ, Park JH, Lee MH, Wee King D, Painter T, Holtkamp D, Dubois P, Wang C. 2010. Effect of injection tool on incidence of head and neck abscesses at slaughter. J Swine Health Prod 18: 290-293.
  12. Knowles NJ, Samuel AR. 2003. Molecular epidemiology of foot-and-mouth disease virus. Virus Res 91: 65-80. https://doi.org/10.1016/S0168-1702(02)00260-5
  13. Mckercher PD, Gailiunas P, Burrows R, Capstick PB. 1971. Reaction of swine to oil-adjuvanted inactivated foot-andmouth disease virus vaccine inoculated by intramuscular and subcutaneous routes. Archiv fur die gesamte Virusforschung 35: 364-377. https://doi.org/10.1007/BF01241917
  14. Miller WH Jr, Scott DW. 1990. Efficacy of chlorpheniramine maleate for management of pruritus in cats. J Am Vet Med Assoc 197: 67-70.
  15. Oda K, Tsukahara F, Kubota S, Kida K, Kitajima T, Hashimoto S. 2006. Emulsifier content and side effects of oil-based adjuvant vaccine in swine. Res Vet Sci 81: 51-57. https://doi.org/10.1016/j.rvsc.2005.10.007
  16. Office International des Epizooties (OIE). 2016. Foot and Mouth Disease, OIE Terrestrial Mannual, pp. 1-31 (Chapter 2.1.8).
  17. Office International des Epizooties (OIE). 2017. Weekly Disease Information, https://www.oie.int/wahis_2/public/wahid.php/Diseaseinformation/WI.
  18. Park JH, Lee KN, Kim SM, Lee HS, Ko YJ, Tark DS, Shin YK, Seo MG, Kim B. 2014. Reemergence of foot-and-mouth disease, South Korea, 2000-2011. Emerg Infect Dis 20: 2158-2161. https://doi.org/10.3201/eid2012.130518
  19. Park JH, Lee KN, Ko YJ, Kim SM, Lee HS, Shin YK, Sohn HJ, Park JY, Yeh JY, Lee YH, Kim MJ, Joo YS, Yoon H, Yoon SS, Cho IS, Kim B. 2013. Control of foot-andmouth disease during 2010-2011 epidemic, South Korea. Emerg Infect Dis 19: 655-659. https://doi.org/10.3201/eid1904.121320
  20. Park JH, Tark D, Lee KN, Lee SY, Ko MK, Lee HS, Kim SM, Ko YJ, Seo MG, Chun JE, Lee MH, Kim B. 2016. Novel foot-and-mouth disease virus in Korea, July-August 2014. Clin Exp Vaccine Res 5: 83-87. https://doi.org/10.7774/cevr.2016.5.1.83
  21. Parker R, Decille S, Dupuis L, Bertrand F and Aucouturier J. 2009. Adjuvant formulation for veterinary vaccines: Montanide$^{TM}$ Gel safety profile. Procedia in Vaccinology 1: 140-147. https://doi.org/10.1016/j.provac.2009.07.026
  22. Shin JH, Sohn HJ, Choi KS, Kwon BJ, Choi CU, Kim JH, Hwang EK, Park JH, Kim JY, Choi SH, Kim OK. 2003. Identification and isolation of foot-and-mouth disease virus from primary suspect cases in Korea in 2000. J Vet Med Sci 65: 1-7. https://doi.org/10.1292/jvms.65.1
  23. Singh M, O'Hagan DT. 2003. Recent advances in veterinary vaccine adjuvants. Inter J Parasitol 33: 469-478. https://doi.org/10.1016/S0020-7519(03)00053-5
  24. Stewart-Tull, D.E.S. (Ed.). 1995. The Theory and Practical Application of Adjuvants. Wiley, Chichester, England.
  25. Straw BE, MacLachlan NJ, Corbett WT, Carter PB, Schey HM. 1985. Comparison of tissue reactions produced by Haemophilus pleuropneumoniae vaccines made with six different adjuvants in swine. Can J Comp Med 49: 149-151.
  26. Tizard IR (Ed.). 2000. Veterinary immunology. An introduction, sixth ed. W.B. Saunders Company, PA, USA.
  27. Valtulini S, Macchi C, Ballanti P, Cherel Y, Laval A, Theaker JM, Bak M, Ferretti E, Morvan H. 2005. Aluminium hydroxide-induced granulomas in pigs. Vaccine 23: 3999-4004. https://doi.org/10.1016/j.vaccine.2004.06.058
  28. Wee SH, Park JY, Joo YS, Lee JH, An SH. 2004. Control measures implemented during the 2002 foot-and-mouth disease outbreak in the Republic of Korea. Vet Rec 154: 598-600. https://doi.org/10.1136/vr.154.19.598
  29. Yeruham I, Yadin H, Haymovich M, Perl S. 2001. Adverse reactions to FMD vaccine. Vet Dermatol 12: 197-201. https://doi.org/10.1046/j.0959-4493.2001.00221.x